Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-08 · accession 0000950170-24-124296 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-08 | 2024-11-08 | VKTX | MACARTNEY LAWSON | Dir | M - OptEx | $5.80 | +2,000 | 50.0K | +4% | +$11.6K |
| D | 2024-11-08 | 2024-11-08 | VKTX | MACARTNEY LAWSON | Dir | S - Sale+OE | $68.67 | -2,000 | 48.0K | -4% | -$137.3K |
| D | 2024-11-08 | 2024-11-08 | VKTX | MACARTNEY LAWSON | Dir | M - OptEx | $0.00 | -2,000 | 20.0K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2024-11-08 | M | A | 2,000 | $5.80 | 49,965 | D | — | — | |
| 2 | Common | Common Stock, par value $0.00001 per share | 2024-11-08 | S | D | 2,000 | $68.67 | 47,965 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-11-08 | M | D | 2,000 | $0.00 | 20,000 | D | $5.80 · 2022-01-04 to 2031-01-04 | 2,000 Common Stock |